Dr. Reddy's Laboratories introduces 'Obeda', a semaglutide version for diabetes management in India. Aims to expand its...
Indian startups raised $228.4M across 21 deals amidst global market uncertainties. Fintech leads, followed by e-commerce. Key...
Dr. Reddy's introduces Obeda, a generic semaglutide injection, the first DCGI-approved treatment for Type 2 diabetes in...
Delhi Police seals United News of India (UNI) office following a Delhi High Court order related to...
Diesel prices surge in India due to geopolitical tensions, impacting manufacturing, logistics, and infrastructure. Industries face increased...
Can Alphabet's (GOOGL) stock reach $350 by year-end? Financial analysis examines growth, market factors, and the plausibility...
Indian airlines challenge a government order for free seat selection, warning of potential fare increases. The FIA...
Novo Nordisk to monitor generic semaglutide entrants in India after patent expiration. Tracking market strategies amid potential...
Discover custom metal embossing seal inserts: hand-engraved branding solutions for personalized stationery and promotional items. Niche manufacturing...
Neo Group, a Mumbai-based wealth advisory firm, achieves unicorn status after securing $53 million in funding led...